Patent Analysis On Biopharmaceutics And Corresponding Research On Developmental Countermeasures In China

Background: As a new branch of modern biotechnology, gene therapy studies have been highly thought all over the world in company with the development of modern biotechnology and have brought great hope to the therapy of cancers. Biopharmaceutical industry in china has made rapid progress in the last 10 years. To date, gene therapy for cancers in china has also been studied. Due to the features of new technologies of modem biotechnology and gene therapy for cancers, expert methods should be used to analyse the industry and related developing technologies. As a unique analytical technique, patent analysis can translate patent data into competitive intelligence which benefits the analysis of the current status and the competitive environment, forecasts technological trends, estimates the competitive ability of the area, and helps to make decisions for it. In this paper patent analysis is used to analyse the current status and the trends. Comparative studies of china and the world in the area of gene therapy are also conducted.Objects: After patent data of gene therapy for cancers in china and abroad collected, indicators and techniques of patent analysis are used to acquire the current status and the technological trends in the area of gene therapy for cancers. By this means we can find out the hotspots and estimate the current researches and development of facilities. Compared the situation about gene therapy for cancers in china with that of thewhole world, the developmental countermeasures are put forward correspondingly after disadvantages of the area in china being pointed out.Methods: Current status of biopharmaceutical industry in china and abroad is analysed first as a whole. Then using the technique of patent analysis and the following indicators such as patent numbers of past years, technology life circle, patent technology area, the competitive ability of facilities and so on. We analysed the patents in the area of gene therapy for cancers. SWOT method is also used to analyse the results from patent analysis, and then the developmental countermeasures are put forward.Results: Gene therapy for cancers in the whole world is under the stage of R&D recently, but still no drugs come into market. After zealously pursued for several years, gene therapy for cancers has gone into a stable developing stage gradually. But in china it is also still in initial research stage and there is a great distance between china and some developed countries in these aspects such as fundamental researches, clinical trials, et al.Countermeasures: According to the results of SWOT analysis, a series of developmental countermeasures on gene therapy for cancers in china are put forward in such aspects as how to enhance fundamental researches, encourage clinical trials, and push forward its industrialization. In short, the countermeasures are to promote collaborate widely between scientific & technological facilities and pharmaceutical enterprises in China and abroad, and offer more convenient conditions for applications of patents and clinical trials making full use of government policy.